GDF2 and ovarian carcinoma: In prostate52 and breast cancer,50 BMP9 exerts tumour‐suppressive activity, since it inhibits migration, growth and invasion, whereas in osteosarcoma53 and ovarian cancer,54 it acts to promote proliferation.